Records containing: Retinitis Pigmentosa
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-06-05Phase 3 Study to Evaluate the Safety and Efficacy of AAV5-hRKp.RPGR for the Treatment of Japanese X-linked Retinitis Pigmentosa Associated With Pathogenic Variants in Retinitis Pigmentosa GTPase Regulator (RPGR)
-
CLINICAL_TRIALS study record update · 2026-04-24Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls
-
CLINICAL_TRIALS study record update · 2026-04-23An Open-label, Phase II Study of ADX-2191 in Subjects With Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-04-20Rod and Cone Mediated Function in Retinal Disease
-
CLINICAL_TRIALS study record update · 2026-04-17A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Sheets (DSP-3077) in Adults With Retinitis Pigmentosa (RP)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-14Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 3 Study to Evaluate the Safety and Efficacy of AAV5-hRKp.RPGR for the Treatment of Japanese X-linked Retinitis Pigmentosa Associated With Pathogenic Variants in Retinitis Pigmentosa GTPase Regulator (RPGR)
-
CLINICAL_TRIALS study record update · 2026-04-13An Expanded Access Program for Retinitis Pigmentosa in Adults Aged 18 Years and Older
-
CLINICAL_TRIALS study record update · 2026-04-13A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation-Associated Retinal Dystrophy
-
CLINICAL_TRIALS study record update · 2026-04-13A Randomized, Masked, Sham-Controlled Phase 2 Trial of the Safety of a Single Intravitreal Injection of jCell (Famzeretcel) for the Treatment of Retinitis Pigmentosa (RP)
-
CLINICAL_TRIALS study record update · 2026-04-03Treatment With 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients - a Randomized Crossover Double Masked Study
-
CLINICAL_TRIALS study record update · 2026-03-31Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
-
CLINICAL_TRIALS study record update · 2026-03-31Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-02 in Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 3, Multi-Center, Randomized Study to Assess The Efficacy, Safety and Tolerability of Subretinal OCU400 Gene Therapy for the Treatment of Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-03-04Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS)
-
CLINICAL_TRIALS study record update · 2026-02-27NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-02-27Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-02-27A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
-
CLINICAL_TRIALS study record update · 2026-02-25Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-02-25Role of Umbilical Cord-derived Stem Cell Transplantation and Conditioned Medium to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
-
CLINICAL_TRIALS study record update · 2026-02-20Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-015 in Patients With Retinitis Pigmentosa or Choroideremia (ENVISION)
-
CLINICAL_TRIALS study record update · 2026-02-13A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of OCT-980 in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa
-
CLINICAL_TRIALS study record update · 2026-02-04Rate of Progression of PCDH15-Related Retinal Degeneration in Usher
-
CLINICAL_TRIALS study record update · 2026-01-29A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From Retinopathy
-
CLINICAL_TRIALS study record update · 2026-01-23Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP in Patients With Retinitis Pigmentosa